语言版本

Time of issue:2021-09-02 16:56:33

中文 English





搜索

Search





Homepage

/

Product

/

API

All categories



No.	Name	CAS#	Therapeutic Category	US-DMF	ASMF	CEP	CDE
1	Acrivastine	87848-99-5	Antiallergic-Antihistamines	√	√		√
2	Bepotastine Besilate	190786-44-8	Antiallergic-Antihistamines	√	√		√
3	Bilastine	202189-78-4	Antiallergic-Antihistamines	√	√		√
4	Levocetirizine HCI	130018-87-0	Antiallergic-Antihistamines	√	√		√
5	Olopatadine HCI	140462-76-6	Antiallergic-Antihistamines	√	√		√
6	Perfluorohexyloctane	133331-77-8	Ophthalmic Agents	√	√		√
7	Isoniazid	54-85-3	Antiinfectives for System Use	√	√		√
8	Linezolid	165800-03-3	Antiinfectives for System Use	√	√		√
9	Moxifloxacin HCI	186826-86-8	Antiinfectives for System Use	√	√	√	√
10	P-Aminosalicylic Acid	133-09-5	Antiinfectives for System Use				√
11	Pyrazinamide	98-96-4	Antiinfectives for System Use				√
12	Rifabutin	72559-06-9	Antiinfectives for System Use				√
13	Rifapentine	61379-65-5	Antiinfectives for System Use				√
14	Tedizolid Phosphate	856867-55-5	Antiinfectives for System Use	√	√		√
15	Anastrozole	120511-73-1	Oncology				√
16	Bendamustine HCI	3543-75-7	Oncology	√	√		√
17	Calcium Levofolinate	80433-71-2	Oncology	√	√		√
18	Crizotinib	877399-52-5	Oncology	√	√		√
19	Enzalutamide	915087-33-1	Oncology	√	√		√
20	Etoposide Phosphate	117091-64-2	Oncology				√
21	Fulvestrant	129453-61-8	Oncology	√	√	√	√
22	Ibrutinib	936563-96-1	Oncology				√
23	Nintedanib Esylate	656247-18-6	Oncology	√	√		√
24	Palonosetron HCI	135729-62-3	Oncology				√
25	Ruxolitinib Phosphate	1092939-17-7	Oncology	√	√		√
26	Acitretin	55079-83-9	Retinoids	√	√	√	√
27	Adapalene	106685-40-9	Retinoids				√
28	Alitretinoin	5300-03-08	Retinoids	√	√
29	Bexarotene	153559-49-0	Retinoids	√	√
30	Isotretinoin	4759-48-2	Retinoids	√	√	√	√
31	Tazarotene	118292-40-3	Retinoids				√
32	Tretinoin	302-79-4	Retinoids	√	√	√	√
33	Viaminate	53839-71-7	Retinoids				√
34	Bifonazole	60628-96-8	Antifungals
35	Butenafine HCI	101827-46-7	Antifungals				√
36	Econazole Nitrate	24169-02-6	Antifungals				√
37	Naftifine HCI	65473-14-5	Antifungals	√	√		√
38	Posaconazole	171228-49-2	Antifungals	√	√		√
39	Benzoyl Peroxide	94-36-0	Dermatologicals				√
40	Calcipotriol Anhydrous	112965-21-6	Dermatologicals	√	√	√	√
41	Calcipotriol Monohydrate	147657-22-5	Dermatologicals	√	√	√	√
42	Dapsone	80-08-0	Dermatologicals	√	√		√
43	Imiquimod	99011-02-6	Dermatologicals				√
44	Methoxsalen	298-81-7	Dermatologicals				√
45	Penciclovir	39809-25-1	Dermatologicals				√
46	Crisaborole	906673-24-3	Dermatologicals				√
47	Betamethasone Dipropionate	5593-20-4	Glucocorticoid				√
48	Betamethasone Sodium Phosphate	151-73-5	Glucocorticoid				√
49	Clobetasone Butyrate	25122-57-0	Glucocorticoid				√
50	Desonide	638-94-8	Glucocorticoid				√
51	Fluticasone Propionate	80474-14-2	Glucocorticoid				√
52	Halometasone	50629-82-8	Glucocorticoid				√
53	Hydrocortisone Butyrate	13609-67-1	Glucocorticoid				√
54	Methylprednisolone Aceponate	86401-95-8	Glucocorticoid
55	Methylprednisolone Succinate	2921-57-5	Glucocorticoid				√
56	Mometasone Furoate	83919-23-7	Glucocorticoid				√
57	Benidipine HCI	91599-74-5	Cardiovascular Agents	√	√		√
58	Nicorandil	65141-46-0	Cardiovascular Agents				√
59	Finerenone	1050477-31-0	Diabetes	√	√		√
60	Nateglinide	105816-04-4	Diabetes				√
61	Benserazide HCI	14919-77-8	Others				√
62	Mirogabalin Besilate	1138245-21-2	Others
63	Nafamostat Mesilate	82956-11-4	Others				√
64	Paricalcitol	131918-61-1	Others	√	√		√
65	Roflumilast	162401-32-3	Others	√	√
66	Topiroxostat	577778-58-6	Others				√
67	Sivelestat Sodium Hydrate	201677-61-4	Others				√

Finerenone

Number of views:

1000

Keywords:

Fulvestrant

FASLODEX is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

Number of views:

1000

Keywords:

treatment

disease

indicated

metastatic

in

for

progression

is

faslodex

Nintedanib esylate

Nintedanib esylate is a small molecule tyrosine kinase inhibitor with antifibrotic and anti-inflammatory activities for the treatment of idiopathic pulmonary fibrosis.

Number of views:

1000

Keywords:

small

treatment

for

pulmonary

is

the

with

fibrosis.

kinase

Ruxolitinib phosphate

Ruxolitinib phosphate is indicated for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis (PMF) (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis (PPV-MF), orpost-essential thrombocythemia myelofibrosis (PET-MF).

Number of views:

1000

Keywords:

myelofibrosis

known

Bendamustine HCl

Bendamustine HCl was originally manufactured in East Germany (former German Democratic Republic) in 1963.

Number of views:

1000

Keywords:

Bendamustine

treatment

Olopatadine HCl

Olopatadine HCl was developed by Kyowa Hakko Kirin, and it was first approved by the FOOD and Drug Administration (FDA) of the United States on December 18, 1996,

Number of views:

1000

Keywords:

Olopatadine

Patanol